Holen Sie sich die Stockscreener-App
0.8501
5.20%
0.0421
Schlusskurs vom Vortag:
$0.808
Offen:
$0.83
24-Stunden-Volumen:
247.54K
Relative Volume:
1.00
Marktkapitalisierung:
$31.08M
Einnahmen:
$928.00K
Nettoeinkommen (Verlust:
$-11.11M
KGV:
-2.3911
EPS:
-0.3555
Netto-Cashflow:
$-10.40M
1W Leistung:
+7.57%
1M Leistung:
-8.92%
6M Leistung:
-33.59%
1J Leistung:
-16.66%
1-Tages-Spanne:
$0.81
$0.88
1-Wochen-Bereich:
$0.78
$0.88
52-Wochen-Spanne:
$0.7006
$1.45
Renovorx Inc Stock (RNXT) Company Profile
Firmenname
Renovorx Inc
Sektor
Branche
Telefon
408-800-2649
Adresse
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Compare RNXT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
0.8481 | 29.61M | 928.00K | -11.11M | -10.40M | -0.3555 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.80 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.16 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.65 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Renovorx Inc Aktie (RNXT) Neueste Nachrichten
Gains Recap: What hedge funds are buying Arko CorpRate Cut & AI Forecast Swing Trade Picks - baoquankhu1.vn
Returns Recap: Can RenovoRx Inc expand its profit margins2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
What dividend safety score for RenovoRx Inc. stockEarnings Recap Report & Real-Time Volume Surge Alerts - Naître et grandir
Market Review: How much upside does RenovoRx Inc have2025 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
Insider Buy: Is RenovoRx Inc stock a value trapJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Macro: What chart patterns are forming on RenovoRx IncRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Block Trades: Will RenovoRx Inc benefit from rate cuts2025 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Guidance Update: Is RenovoRx Inc stock overvalued or fairly pricedJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
RenovoRx Advancing RenovoCath Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - marketscreener.com
US Market Recap: Whats the outlook for RenovoRx Incs sectorM&A Rumor & AI Enhanced Trading Alerts - baoquankhu1.vn
RenovoRx advances RenovoCath adoption at U.S. cancer centers - Yahoo Finance
RNXT Should I Buy - Intellectia AI
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - Investing News Network
After 700 cancer procedures, RenovoCath gets new doctor-led commercial push - Stock Titan
Targeted chemo delivery for pancreatic cancer to feature at 2026 SIR meeting - Stock Titan
RNXT PE Ratio & Valuation, Is RNXT Overvalued - Intellectia AI
RenovoRx (RNXT) Price Target Increased by 10.66% to 6.88 - Nasdaq
Hedge Fund Bets: Will eBay Inc Preferred Security stock hit new highs in YEAR2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is RenovoRx Inc. stock overvalued or fairly pricedSwing Trade & Daily Technical Forecast Reports - mfd.ru
Dow Update: How much upside does RenovoRx Inc haveJuly 2025 Market Mood & Weekly Top Stock Performers List - baoquankhu1.vn
RenovoRx (NASDAQ:RNXT) vs. MetaVia (NASDAQ:MTVA) Head-To-Head Survey - Defense World
Mark Voll Joins RenovoRx as Chief Financial Officer - Medical Product Outsourcing
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
RenovoRx (NASDAQ:RNXT) Price Target Raised to $13.00 at Ascendiant Capital Markets - Defense World
RenovoRx (RNXT): Analyst Raises Price Target Following Positive Outlook | RNXT Stock News - GuruFocus
Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Sahm
Why RenovoRx Inc. stock remains resilientTrade Performance Summary & Safe Entry Point Alerts - mfd.ru
Is RenovoRx Inc. a top pick in the sector2025 Biggest Moves & Growth Focused Entry Point Reports - mfd.ru
Can RenovoRx Inc. deliver consistent EPS growthJuly 2025 Trends & Expert Approved Trade Ideas - mfd.ru
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - MSN
Bank Watch: Can RenovoRx Inc deliver consistent EPS growth2025 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Catalysts: What drives XYZGs stock price2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
What’s the beta of RenovoRx Inc. stockJuly 2025 Snapshot & Accurate Buy Signal Notifications - mfd.ru
RenovoRx formation of RenovoCath Medical Advisory Board to support clinical and strategic initiatives - marketscreener.com
RenovoRx Forms Medical Advisory Board to Support RenovoCath - Intellectia AI
RenovoRx Establishes RenovoCath® Medical Advisory Board - Investing News Network
Renovorx Formation Of Renovocath Medical Advisory Board To Support Clinical And Strategic Initiatives - TradingView
RenovoRx, Inc. Establishes Medical Advisory Board to Advance RenovoCath Clinical Initiatives and Targeted Oncology Therapies - Quiver Quantitative
RenovoRx, Inc. Establishes RenovoCath Medical Advisory Board - marketscreener.com
RNXT SEC FilingsRenovorx Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Ideas: Is RenovoRx Inc stock overvalued or fairly pricedWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
RenovoRx, Inc. Announces Change of Principal Accounting Officer - marketscreener.com
RenovoRx Appoints Veteran Executive Mark Voll as CFO - TipRanks
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer - Investing News Network
Renovorx, Inc. Appoints Mark Voll as Chief Financial Officer, Effective from February 1, 2026 - marketscreener.com
RenovoRx announces new clinical data on TAMP therapy platform - TipRanks
RenovoRx to Present New Clinical Data on Optimizing Drug Delivery in Solid Tumors at 2026 Society of Interventional Oncology Annual Meeting - Quiver Quantitative
How real-time pressure readings could sharpen chemo targeting - Stock Titan
Exit Recap: Is SunCar Technology Group Inc Equity Warrant forming a breakout patternJuly 2025 Market Mood & Community Trade Idea Sharing Platform - baoquankhu1.vn
RenovoRx (NASDAQ:RNXT) Upgraded at Jones Trading - Defense World
Pharma News: How does RenovoRx Inc perform in inflationary periods2025 Volume Leaders & Weekly Momentum Stock Picks - baoquankhu1.vn
Finanzdaten der Renovorx Inc-Aktie (RNXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):